Webinars

This webinar emerges in the sequence of relevant topics highlighted in the ISPOR Science Strategy (particularly the Special Populations and Technologies and Health Economics, Access and Policy sections) and the Special Interest Group on biosimilars, by specifically reflecting on how to tackle inefficiencies of healthcare systems in the future with biosimilars. The session takes a global perspective on the future of biosimilars, and presents an insightful exchange of views from experts from various regions worldwide.

Although sharing data securely is a mission-critical capability for healthcare providers, it is an elusive step in driving true interoperability. With exploding health data volumes and the pressure to inform patient outcomes and experiences with data-driven insights, healthcare providers need unfettered and governed access to valuable data sources within and outside of their organization.

While the FDA has set guidelines on proactive manufacturer communications of healthcare economic information (HCEI) to payers, there still appears to be a gap between what payers are asking for and what manufacturers are providing. So why the gap, and how might this be impacting payer decision making? And what might prove helpful for manufacturers to enhance this exchange? Join our panel for research findings and insights into these critical questions, along with strategies to close the gap.

Join us for a moderated panel discussion with IQVIA leaders following the release of a recent IQVIA Institute report on The Global Use of Medicines 2022.

Join this webinar to hear from regulatory affairs professionals, pharmaceutical company executives and leaders in data and AI as they discuss the challenges and opportunities for RWE across the drug lifecycle and lessons learned building successful RWE analytics programs.

This webinar will be useful for researchers, regulators, academics, industry sponsors, and instrument developers in the clinical outcomes assessment (COA) field working on the development, evaluation, and implementation of performance outcome (PerfO) measures for use in capturing clinical benefits in treatment trials for medical label claims. Speakers will present work to date and invite audience feedback on several areas where there is a lack of consensus.

This unique training focuses on leveraging patient-centric Real-World Evidence (RWE) to accelerate the patient and market access of innovative and potentially transformative Orphan Medicinal Products (OMPs). Delegates will address the challenge of early market access based on fewer and less mature data, with the creation of an Early Value Proposition and a Patient-Centric Evidence Generation Plan that comprehensively support value demonstration, product positioning, and that meets stakeholders’ requirements.

As the industry faces significant staff shortages, the implementation of automation becomes all the more critical for ensuring patients can continue to receive the care that they need. We must pivot our approach now, fully embrace the automation of menial clinician and administrative tasks and relieve our overstretched staff of these unnecessary burden

On September 26 2021 the German population voted for a change in politics. In December 2021 the new government started their work including Prof. Dr. Karl Lauterbach as their new Ministry of Health. What does this change potentially mean to the pharmaceutical industry especially for market access?

Chris Deacon is going to give us the inside scoop on the successes and challenges in managing the highest-visibility health benefit in the country north of Bentonville...and what she learned and we can learn from her experience.

Join our upcoming virtual discussions that offer a deep-dive into specific research areas. Each meeting will focus on a specific challenge and showcase the innovative approaches of different research organizations. During the live Q&A session all attendees will participate in lively discussion on the given problem and solutions. We hope to see you there!

The EPP live-interactive learning programs, to improve your pricing knowledge with high quality content, develop new skills and meet international pricing peers all in the comfort of your own home/office.

Reuters Events: Pharma USA 2022 (March 16-17, 2022, Philadelphia – formerly eyeforpharma Philadelphia) is where 1,000+ pharma leaders and critical stakeholders will unite to draw the blueprints and construct frameworks for the future of our industry. Prioritize customer journeys over brand journeys, commit to a people-driven, tech-enabled transformation and inject data into every decision made to realize innovation that transforms lives.

Join global healthcare leaders, in-person and virtually, as they convene at ISPOR 2022, the leading global conference for Health Economics and Outcomes Research (HEOR), May 15-18, for discussion and dissemination of the latest trends in healthcare. This must-attend event provides you with dedicated opportunities to network in-person and virtually with your peers, HEOR experts, and thought leaders and to discuss with a global audience how we establish, incentivize, and share value sustainable for health systems, patients, and technology developers.

This webinar will educate on the opportunities and challenges of using Real World Evidence (RWE) in medical communications and publication planning. Multiple stakeholder perspectives including that of publication professionals, journal editors, RWE writers and consultants will be discussed.